HomeInsightsStock Comparison

Novartis India Ltd vs Zenlabs Ethica Ltd Stock Comparison

Novartis India Ltd vs Zenlabs Ethica Ltd Stock Comparison

Last Updated on: Jun 25, 2025

Key Highlights

  • The Latest Trading Price of Novartis India Ltd is ₹ 1015 as of 24 Jun 15:30.
  • The P/E Ratio of Novartis India Ltd changed from 123.1 on March 2020 to 29.8 on March 2024 . This represents a CAGR of -24.70% over 5 yearsThe P/E Ratio of Zenlabs Ethica Ltd changed from 17.9 on March 2021 to 63.8 on March 2024 . This represents a CAGR of 37.40% over 4 years.
  • The Market Cap of Novartis India Ltd changed from ₹ 1240 crore on March 2020 to ₹ 2539 crore on March 2024 . This represents a CAGR of 15.41% over 5 yearsThe Market Cap of Zenlabs Ethica Ltd changed from ₹ 23.7 crore on March 2020 to ₹ 27.02 crore on March 2024 . This represents a CAGR of 2.66% over 5 years.
  • The revenue of Novartis India Ltd for the Mar '25 is ₹ 94.51 crore as compare to the Dec '24 revenue of ₹ 103.6 crore. This represent the decline of -8.77% The revenue of Zenlabs Ethica Ltd for the Mar '25 is ₹ 13.03 crore as compare to the Dec '24 revenue of ₹ 12.73 crore. This represent the growth of 2.36%.
  • The ebitda of Novartis India Ltd for the Mar '25 is ₹ 34.54 crore as compare to the Dec '24 ebitda of ₹ 36.18 crore. This represent the decline of -4.53% The ebitda of Zenlabs Ethica Ltd for the Mar '25 is ₹ 0.7 crore as compare to the Dec '24 ebitda of ₹ 0.68 crore. This represent the growth of 2.94%.
  • The net profit of Novartis India Ltd changed from ₹ 20.26 crore to ₹ 29.3 crore over 8 quarters. This represents a CAGR of 20.26% The net profit of Zenlabs Ethica Ltd changed from ₹ 0.07 crore to ₹ 0.09 crore over 8 quarters. This represents a CAGR of 13.39% .
  • The Dividend Payout of Novartis India Ltd changed from 244.84 % on March 2020 to 72.43 % on March 2024 . This represents a CAGR of -21.62% over 5 yearsThe Dividend Payout of Zenlabs Ethica Ltd changed from 33.21 % on March 2023 to 0 % on March 2024 . This represents a CAGR of -100.00% over 2 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Novartis India Ltd

  • Novartis India Limited (NIL) is a subsidiary of Swiss giant Novartis, the world's second largest pharmaceutical company was incorporated on 13 December 1947.
  • The Company is engaged in manufacturing and marketing of drugs, pharmaceutical products and formulations for consumer healthcare and animal healthcare; it operates into four segments such as Pharmaceuticals, Generics, Over the Trade Counter and Animal Health. The origin of Novartis is linked to the origin of three distinct companies namely Geigy, Ciba, and Sandoz.
  • The history of Geigy goes back to the middle of the 18th century, Ciba was founded around 1860, and Sandoz was set-up in 1886.
  • In 1970 Ciba and Geigy merged to form Ciba-Geigy Ltd. Sandoz and Ciba-Geigy Ltd continued as separate entities for the next 25 years.
  • In 1996, in one of the largest corporate mergers in history Sandoz and Ciba-Geigy Ltd.

About Zenlabs Ethica Ltd

  • Zenlabs Ethica Limited (Formerly known Neelkanth Technologies Limited) was incorporated in 1993.
  • The Company is one of the top 10 pharmaceutical contract marketing and trading companies in India that markets and distribute a wide range of branded drugs including Gastrointestinal disorders, Anti-Diabetics, Anti-Hypertensive Drugs, Anti-Infective, Soaps & Anti-Bacterial Drugs, Nutraceuticals, etc., It boasts of a comprehensive global network.
  • It deals into marketing and distribution of pharmaceutical products and has grown to be of India's top pharmaceutical companies in 2019. The Company has been launched in collaboration with Zenlabs Pharmaceutical Inc, Canada.
  • The strength lies in quality, affordable and branded drugs in enhancing the quality of life of people.
  • Apart from this, it offers more than 600 products across therapeutic segments, making it a leader among pharmaceutical companies in India.

Novartis India Ltd News Hub

News

Novartis India schedules AGM

Novartis India announced that the 77th Annual General Meeting(AGM) of the company will be ...

Read more

10 May 2025 09:38

News

Board of Novartis India recommends final dividend

Novartis India announced that the Board of Directors of the Company at its meeting held on...

Read more

10 May 2025 09:38

News

Novartis India to announce Quarterly Result

Novartis India will hold a meeting of the Board of Directors of the Company on 9 May 2025....

Read more

28 Mar 2025 09:32

News

Novartis India to hold board meeting

Novartis India will hold a meeting of the Board of Directors of the Company on 28 January ...

Read more

28 Dec 2024 09:37

News

Novartis India schedules board meeting

Novartis India will hold a meeting of the Board of Directors of the Company on 25 October ...

Read more

28 Sep 2024 10:07

News

Novartis India to declare Quarterly Result

Novartis India will hold a meeting of the Board of Directors of the Company on 29 July 202...

Read more

28 Jun 2024 17:50

Zenlabs Ethica Ltd News Hub

News

Zenlabs Ethica to declare Quarterly Results

Zenlabs Ethica will hold a meeting of the Board of Directors of the Company on 12 May 2025...

Read more

08 May 2025 11:05

News

Zenlabs Ethica to declare Quarterly Results

Zenlabs Ethica will hold a meeting of the Board of Directors of the Company on 12 May 2025...

Read more

07 May 2025 11:07

News

Zenlabs Ethica to hold board meeting

Zenlabs Ethica will hold a meeting of the Board of Directors of the Company on 7 February ...

Read more

31 Jan 2025 15:48

News

Zenlabs Ethica to announce Quarterly Result

Zenlabs Ethica will hold a meeting of the Board of Directors of the Company on 12 November...

Read more

07 Nov 2024 16:58

News

Zenlabs Ethica AGM scheduled

Zenlabs Ethica announced that the 31th Annual General Meeting (AGM) of the company will be...

Read more

30 Sep 2024 10:04

News

Zenlabs Ethica announces board meeting date

Zenlabs Ethica will hold a meeting of the Board of Directors of the Company on 7 August 20...

Read more

02 Aug 2024 10:30

SWOT Analysis Of Novartis India Ltd

Strength

1

S

Weakness

0

W

Opportunity

0

O

Threats

0

T

SWOT Analysis Of Zenlabs Ethica Ltd

Strength

1

S

Weakness

0

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Zenlabs Ethica Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Novartis India Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Novartis India Ltd and Zenlabs Ethica Ltd

Which company has a larger market capitalization, Novartis India Ltd or Zenlabs Ethica Ltd?

Market cap of Novartis India Ltd is 2,506 Cr while Market cap of Zenlabs Ethica Ltd is 21 Cr

What are the key factors driving the stock performance of Novartis India Ltd and Zenlabs Ethica Ltd?

The stock performance of Novartis India Ltd and Zenlabs Ethica Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Novartis India Ltd and Zenlabs Ethica Ltd?

As of June 25, 2025, the Novartis India Ltd stock price is INR ₹1015.05. On the other hand, Zenlabs Ethica Ltd stock price is INR ₹32.31.

How do dividend payouts of Novartis India Ltd and Zenlabs Ethica Ltd compare?

To compare the dividend payouts of Novartis India Ltd and Zenlabs Ethica Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions